Europe

Expanding right into Europe

Innovation is the life source of Life Sciences. But strategic and meticulous planning is key to commercial success, especially when entering a new regional market.

Smart Site Selection for Life Sciences Companies

Life science companies have to future-proof their value chain by placing functions, assets and risks in locations where they are planning to have their profits taxed. Structures where profit allocations are made in tax-beneficent locations with little or no substance are no longer viable.
8

How attractive are European Life Sciences Sites?

KPMG’s newest report on leading Life Sciences Clusters in Europe, released on 3 November 2015 at the Bio Europe Congress, reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.
16

Global capital flows into European real estate

The investment activity of global investors is principally focusing on the highly liquid major cities such as London and Paris. However, increased activity was also noted in peripheral markets, which have attracted opportunistic capital mainly from the United States.
9

Switzerland – your gateway to Europe

Multinational companies (MNCs) are under an ever increasing pressure from their stakeholders and from the markets to provide for growth prospects which are at the same time competitive and sustainable. One of the key success factors in this regards is choosing the right location for the right activities.
8

Bullish attitude returns to the property market

The global real estate market will see a resurgence of deal activity over the next 12 months, with Western European markets attracting the lion’s share of investor interest, according to the findings of the 2014 KPMG Real Estate Invest Survey.
8